Physician profile
Mitchell Owen Moskowitz
NPI 1700849189
$3,446.64
in general payments reported to CMS, 2019-2025
34 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $123 · 2021: $35.71 · 2022: $755 · 2023: $1,072 · 2024: $259 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $537.96 | 2022-2025 | Urolift, Barrigel |
| Neotract INC. | $504.45 | 2019-2020 | |
| Boston Scientific Corporation | $420.55 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml, Tria Firm |
| Astellas Pharma US INC | $309.10 | 2019-2023 | Xtandi |
| Procept Biorobotics Corporation | $283.64 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Medtronic, INC. | $177.34 | 2023 | Interstim |
| Janssen Biotech, INC. | $176.42 | 2019-2025 | Rybrevant, Carvykti |
| Progenics Pharmaceuticals, INC. | $121.84 | 2023 | Pylarify |
| Olympus America INC. | $109.93 | 2023-2025 | Itind System |
| Cook Medical LLC | $101.17 | 2019-2025 | Resonance, Cook |
| Axonics, INC. | $87.85 | 2022-2023 | Axonics |
| Sumitomo Pharma America, INC. | $72.95 | 2023-2024 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $56.01 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $46.82 | 2019-2020 | |
| Tolmar, INC. | $40.75 | 2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $34.11 | 2020-2024 | Xyosted |
| Bioprotect Medical, INC. | $31.16 | 2024 | Bioprotect Balloon Implant System |
| Hollister Incorporated | $30.54 | 2023-2024 | Infyna Chic, Onli, Vapro Pocket |
| Myriad Genetic Laboratories, INC. | $26.25 | 2025 | Prolaris |
| Integra Lifesciences Corporation | $25.48 | 2024 | Biofix, Biodoptix, Biodfactor |
| Pfizer INC. | $25.34 | 2025 | |
| 180 Medical, INC. | $24.08 | 2023 | Gentlecath Glide |
| Histosonics, INC. | $22.99 | 2025 | |
| Clarus Therapeutics INC. | $20.31 | 2021 | |
| Abbvie INC. | $20.25 | 2019 | |
| Blue Earth Diagnostics | $19.21 | 2019 | |
| Verity Pharmaceuticals INC. | $18.48 | 2025 | Trelstar |
| Urogen Pharma, INC. | $17.98 | 2023 | Jelmyto |
| Tolmar Pharmaceuticals, INC. | $17.07 | 2022 | |
| Dendreon Pharmaceuticals LLC | $16.12 | 2019 | |
| Coloplast Corp | $16.04 | 2023 | Speedicath |
| Abc Home Medical Supply, INC. | $14.15 | 2024 | |
| Photocure INC | $12.80 | 2020 | |
| Laborie Medical Technologies Corp. | $7.50 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Moskowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.